#generations #researchers #meet #Vigo #debate #future #biomedical #research
Artificial Intelligence and Precision Medicine, inseparable for the future of the sector
The approach could not be explained without the development of this technology, as analyzed by a group of experts who participated in the preparation of the report ‘Applications of Artificial Intelligence in Personalized Precision Medicine’, presented at the sixth edition of the ‘Anticipating’ conference that organized by the Roche Institute Foundation.
+ read more
A state macroproject to promote precision medicine
The IMPaCT Cohort study, promoted by the Carlos III Health Institute of the Ministry of Science, Innovation and Universities through its Network Biomedical Research Center (CIBER), will monitor the health and lifestyle of 200,000 people from all of Spain, 24,000 of them from Catalonia, for twenty years.
+ read more
NG Precision+, the first blood pregnancy test for home use
Towa’s collaboration with NG Biotech will enable the commercial launch of the first and only home-use blood pregnancy test with a patented all-in-one device.
+ read more
BioSpain 2023: Precision medicine, the promising horizon of biotechnology
The development of small molecules, organoids or the identification of new therapeutic targets are crucial aspects in the future of the sector.
+ read more
Precision vaccines: a revolution that limits the cost of its development
The greatest advance ever achieved in the history of medicine now faces a turning point with the possibility of developing, thanks to new technologies, specific doses for population groups, with greater effectiveness and safety. But, to what extent will it be possible to customize them without the expense being exorbitant?
+ read more
Precision medicine and biomarkers: the beginning of a new era
Precision medicine is a paradigm shift in the treatment of cancer patients. Individualizing your medical management implies better clinical care, taking into account the unique characteristics of each patient based on certain biomarkers, obtaining better cure or survival results and reducing undesirable and unnecessary side effects.
+ read more